Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Frozen Shoulder

Ultrasound Guided Continuous Suprascapular Nerve Block With Oral Gabapentin For Pain Management In Patients With Frozen Shoulder

The patients will be randomly allocated into two equal groups (each 20 patients) using sealed opaque numbered envelopes:

Control Group (C Group) : Patients receive continuous US suprascapular nerve block only.

Gabapentin Group (G Group) : Patients receive continuous US suprascapular nerve block with oral gabapentin 300 mg once daily at bed time.

Both groups compared as regard:

Visual Analogue Scale Range of passive and active movements Patients satisfaction complication related to block The total dose of diclofenac sodium

Inclusion Criteria:

• Body mass index ≥ 18 Kg/m2 ≤ 30Kg/m2
• ASA I, II or III.
• Cooperative patients.

Exclusion Criteria:

• local infection at site of injection.
• coagulopathy
• previous history of mental disorders or chronic drug abuse (opioids, tranquilizers)
• known hypersensitivity to any of the drugs used in the study.